Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Gerhardinger

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Diabetes|November 28, 2002
Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathyJing Zhang, Chiara Gerhardinger, Mara Lorenzi
Plos One|May 23, 2012
IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulationYang Liu, Montserrat Biarnés Costa, Chiara Gerhardinger
STAR Protocols|November 19, 2023
High-throughput functional analysis of regulatory variants using a massively parallel reporter assayKate Delfosse, Chiara Gerhardinger, John L Rinn, et al.
Diabetes|January 24, 2003
A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the ratVeronica Asnaghi, Chiara Gerhardinger, Todd Hoehn, et al.
Diabetes|November 25, 2005
Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effectsWei Sun, Chiara Gerhardinger, Zeina Dagher, et al.
Diabetes|April 30, 2009
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathyChiara Gerhardinger, Zeina Dagher, Paola Sebastiani, et al.
Diabetes|September 28, 2006
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathyWei Sun, Peter J Oates, James B Coutcher, et al.
Diabetes|August 28, 2004
Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathyZeina Dagher, Yong Seek Park, Veronica Asnaghi, et al.
The American Journal of Pathology|February 7, 2017
The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal VesselsZeina Dagher, Chiara Gerhardinger, Joseph Vaz, et al.
Diabetes|May 13, 2011
Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brainDeepti Navaratna, Shu-Zhen Guo, Kazhuhide Hayakawa, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Diabetes|November 28, 2002
Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathyJing Zhang, Chiara Gerhardinger, Mara Lorenzi
Plos One|May 23, 2012
IL-1β is upregulated in the diabetic retina and retinal vessels: cell-specific effect of high glucose and IL-1β autostimulationYang Liu, Montserrat Biarnés Costa, Chiara Gerhardinger
STAR Protocols|November 19, 2023
High-throughput functional analysis of regulatory variants using a massively parallel reporter assayKate Delfosse, Chiara Gerhardinger, John L Rinn, et al.
Diabetes|January 24, 2003
A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the ratVeronica Asnaghi, Chiara Gerhardinger, Todd Hoehn, et al.
Diabetes|November 25, 2005
Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effectsWei Sun, Chiara Gerhardinger, Zeina Dagher, et al.
Diabetes|April 30, 2009
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathyChiara Gerhardinger, Zeina Dagher, Paola Sebastiani, et al.
Diabetes|September 28, 2006
A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathyWei Sun, Peter J Oates, James B Coutcher, et al.
Diabetes|August 28, 2004
Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathyZeina Dagher, Yong Seek Park, Veronica Asnaghi, et al.
The American Journal of Pathology|February 7, 2017
The Increased Transforming Growth Factor-β Signaling Induced by Diabetes Protects Retinal VesselsZeina Dagher, Chiara Gerhardinger, Joseph Vaz, et al.
Diabetes|May 13, 2011
Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brainDeepti Navaratna, Shu-Zhen Guo, Kazhuhide Hayakawa, et al.
Pageof 3